These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11214537)

  • 1. Effect of sumatriptan on health care resource use among patients with migraine.
    Joish VN; Cady PS
    Manag Care Interface; 2001 Jan; 14(1):68-72. PubMed ID: 11214537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A migraine prophylaxis educational intervention in a Medicaid population.
    Owens C; Pugmire B; Owens K
    Headache; 2008 Feb; 48(2):267-71. PubMed ID: 18194289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sumatriptan nasal spray for migraine: a review of studies in patients aged 17 years and younger.
    Hämäläinen M; Jones M; Loftus J; Saiers J
    Int J Clin Pract; 2002 Nov; 56(9):704-9. PubMed ID: 12469987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of migraine emergency department utilization in the georgia medicaid population.
    Kwong WJ
    Headache; 2007 Oct; 47(9):1326-33. PubMed ID: 17927649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term tolerability of sumatriptan nasal spray in adolescent patients with migraine.
    Natarajan S; Jabbour JT; Webster CJ; Richardson MS
    Headache; 2004; 44(10):969-77. PubMed ID: 15546259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.
    Winner P; Rothner AD; Wooten JD; Webster C; Ames M
    Headache; 2006 Feb; 46(2):212-22. PubMed ID: 16492230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost savings in migraine associated with less chest pain on new triptan therapy.
    Wang JT; Barr CE; Torigoe Y; Wang E; Rowland CR; Goldfarb SD
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S102-7. PubMed ID: 11859905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache.
    Kaniecki R; Ruoff G; Smith T; Barrett PS; Ames MH; Byrd S; Kori S
    Curr Med Res Opin; 2006 Aug; 22(8):1535-44. PubMed ID: 16870078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixing sumatriptan: a prospective study of stratified care using multiple formulations.
    Kaniecki RG
    Headache; 2001 Oct; 41(9):862-6. PubMed ID: 11703472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
    Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in resource use and outcomes for patients with migraine treated with sumatriptan: a managed care perspective.
    Lofland JH; Johnson NE; Batenhorst AS; Nash DB
    Arch Intern Med; 1999 Apr; 159(8):857-63. PubMed ID: 10219932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zelrix: a novel transdermal formulation of sumatriptan.
    Pierce M; Marbury T; O'Neill C; Siegel S; Du W; Sebree T
    Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
    Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
    Dowson AJ; Massiou H; Lainez JM; Cabarrocas X
    Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sumatriptan for the treatment of undifferentiated primary headaches in the ED.
    Miner JR; Smith SW; Moore J; Biros M
    Am J Emerg Med; 2007 Jan; 25(1):60-4. PubMed ID: 17157685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
    Schreiber CP; Cady RK
    Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack.
    Linde M; Mellberg A; Dahlöf C
    Cephalalgia; 2006 Feb; 26(2):113-21. PubMed ID: 16426264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early treatment of a migraine attack while pain is still mild increases the efficacy of sumatriptan.
    Scholpp J; Schellenberg R; Moeckesch B; Banik N
    Cephalalgia; 2004 Nov; 24(11):925-33. PubMed ID: 15482353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.